Patents by Inventor Fabio DiLisa

Fabio DiLisa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors
    Patent number: 9694014
    Abstract: Administration of a monoamine oxidase inhibitor is useful in the prevention and treatment of muscle dystrophy. Methods and compositions for inhibiting the production of reactive oxygen species in a muscle cell overproducing reactive oxygen species are provided herein.
    Type: Grant
    Filed: July 15, 2013
    Date of Patent: July 4, 2017
    Assignee: Universita Degli Studi di Padova
    Inventors: Paolo Bonaldo, Marcella Canton, Fabio DiLisa, Sara Menazza
  • TREATMENT OF MUSCULAR DYSTROPHIES AND ASSOCIATED CONDITIONS BY ADMINISTRATION OF MONOAMINE OXIDASE INHIBITORS
    Publication number: 20150290201
    Abstract: Administration of a monoamine oxidase inhibitor is useful in the prevention and treatment of muscle dystrophy. Methods and compositions for inhibiting the production of reactive oxygen species in a muscle cell overproducing reactive oxygen species are provided herein.
    Type: Application
    Filed: July 15, 2013
    Publication date: October 15, 2015
    Inventors: Paolo Bonaldo, Marcella Canton, Fabio DiLisa, Sara Menazza
  • TREATMENT OF HEART FAILURE AND ASSOCIATED CONDITIONS BY ADMINISTRATION OF MONOAMINE OXIDASE INHIBITORS
    Publication number: 20150011643
    Abstract: Administration of monoamine oxidase inhibitors is useful in the prevention and treatment of heart failure and incipient heart failure.
    Type: Application
    Filed: July 15, 2014
    Publication date: January 8, 2015
    Inventors: Fabio DiLisa, Ning Feng, Nina Kaludercic, Nazareno Paolocci
  • Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors
    Patent number: 8487008
    Abstract: Administration of a monoamine oxidase inhibitor is useful in the prevention and treatment of muscle dystrophy. Methods and compositions for inhibiting the production of reactive oxygen species in a muscle cell overproducing reactive oxygen species are provided herein.
    Type: Grant
    Filed: June 22, 2011
    Date of Patent: July 16, 2013
    Assignee: Universita degli Studi di Padova
    Inventors: Paolo Bonaldo, Marcella Canton, Fabio DiLisa, Sara Menazza
  • TREATMENT OF MUSCULAR DYSTROPHIES AND ASSOCIATED CONDITIONS BY ADMINISTRATION OF MONOAMINE OXIDASE INHIBITORS
    Publication number: 20120329800
    Abstract: Administration of a monoamine oxidase inhibitor is useful in the prevention and treatment of muscle dystrophy. Methods and compositions for inhibiting the production of reactive oxygen species in a muscle cell overproducing reactive oxygen species are provided herein.
    Type: Application
    Filed: June 22, 2011
    Publication date: December 27, 2012
    Inventors: Paolo Bonaldo, Marcella Canton, Fabio DiLisa, Sara Menazza
  • TREATMENT OF HEART FAILURE AND ASSOCIATED CONDITIONS BY ADMINISTRATION OF MONOAMINE OXIDASE INHIBITORS
    Publication number: 20090286883
    Abstract: Administration of monoamine oxidase inhibitors is useful in the prevention and treatment of heart failure and incipient heart failure.
    Type: Application
    Filed: March 19, 2009
    Publication date: November 19, 2009
    Applicants: Universita' degli Studi di Padova (University of Padua)
    Inventors: Fabio DiLisa, Ning Feng, Nina Kaludercic, Nazareno Paolocci